Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.060
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
1.040
-0.020 (-1.88%)
After-hours: Dec 5, 2025, 6:19 PM EST

Aprea Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
13.7222.8521.6128.7953.08-
Cash & Short-Term Investments
13.7222.8521.6128.7953.08-
Cash Growth
-47.74%5.75%-24.94%-45.76%--
Prepaid Expenses
0.230.730.911.373.51-
Total Current Assets
13.9423.5822.5230.1556.58-
Property, Plant & Equipment
0.070.080.0900.21-
Other Long-Term Assets
0.310.320.04-0.03-
Total Assets
14.3223.9822.6530.1656.82-
Accounts Payable
0.641.351.670.841.77-
Accrued Expenses
2.042.012.192.365.35-
Current Portion of Leases
----0.19-
Current Unearned Revenue
--0.53---
Total Current Liabilities
2.683.364.393.27.32-
Total Liabilities
2.683.364.393.27.32-
Common Stock
0.010.01000-
Additional Paid-In Capital
352.72350.97335.64330.06241-
Retained Earnings
-331.19-321.04-308.08-293.8-181.13-
Comprehensive Income & Other
-10.63-10.63-10.61-10.62-10.36-
Total Common Equity
10.9119.3116.9525.6449.51-
Shareholders' Equity
11.6420.6218.2626.9549.51-
Total Liabilities & Equity
14.3223.9822.6530.1656.82-
Total Debt
----0.19-
Net Cash (Debt)
13.7222.8521.6128.7952.89-
Net Cash Growth
-47.74%5.75%-24.94%-45.57%--
Net Cash Per Share
2.254.155.9717.3749.69-
Filing Date Shares Outstanding
6.315.495.433.731.061.06
Total Common Shares Outstanding
5.985.483.742.661.061.06
Working Capital
11.2620.2218.1426.9549.27-
Book Value Per Share
1.833.524.549.6645.97-
Tangible Book Value
10.9119.3116.9525.6449.51-
Tangible Book Value Per Share
1.833.524.549.6645.97-
Machinery
-0.150.140.050.14-
Source: S&P Capital IQ. Standard template. Financial Sources.